Uploaded July 2025 | Updated November 2026, 3 days ago
Speaker: Mariko Okada, Professor at the Institute for Protein Research, Osaka University (Japan).
Patient heterogeneity makes cancer treatment and drug development difficult and costly. Therefore, the development of computational methods to find prognostic markers for individualised treatment and drug screening is urgently needed. To address this problem, we employ both network/pathway-based simulation (mechanistic modelling) and molecular-based simulation (molecular dynamics (MD) simulation).
Mechanistic modeling of gene networks using ordinary differential equations (ODEs) is regarded as a promising approach to uncover regulatory mechanisms and identify drug targets in human diseases. We developed Pasmopy (Patient-Specific Modelling in Python), a computational framework for patient stratification based on in silico signalling dynamics. With this framework, we constructed a comprehensive mechanistic model of the ErbB receptor - c-Myc signalling network, trained on phospho-proteomics data from breast cancer cell lines. We then performed a simulation of 377 breast cancer patients using transcriptome data from The Cancer Genome Atlas (TCGA) as the model's initial value. Through this approach, we successfully predicted the key maker genes associated with poor prognosis of triple-negative breast cancer (TNBC) based on the time-course patterns of in silico signalling dynamics, using deep learning method.
In this study, we also developed a new computational tool called Text2model, which transforms the descriptions of biochemical reactions into mechanistic models. Building on Text2Model, we are currently developing natural language processing (NLP) methods to automatically construct mathematical models from the literature and public databases, and to predict gene-drug interactions.
Further information here: bsc.es/research-and-development/research-seminars/sorswomeninbsc-multi-scale-cancer-signaling-network-modeling-using-natural-language-processing
Speaker: Mariko Okada, Professor at the Institute for Protein Research, Osaka University (Japan).
Patient heterogeneity makes cancer treatment and drug development difficult and costly. Therefore, the development of computational methods to find prognostic markers for individualised treatment and drug screening is urgently needed. To address this problem, we employ both network/pathway-based simulation (mechanistic modelling) and molecular-based simulation (molecular dynamics (MD) simulation).
Mechanistic modeling of gene networks using ordinary differential equations (ODEs) is regarded as a promising approach to uncover regulatory mechanisms and identify drug targets in human diseases. We developed Pasmopy (Patient-Specific Modelling in Python), a computational framework for patient stratification based on in silico signalling dynamics. With this framework, we constructed a comprehensive mechanistic model of the ErbB receptor - c-Myc signalling network, trained on phospho-proteomics data from breast cancer cell lines. We then performed a simulation of 377 breast cancer patients using transcriptome data from The Cancer Genome Atlas (TCGA) as the model's initial value. Through this approach, we successfully predicted the key maker genes associated with poor prognosis of triple-negative breast cancer (TNBC) based on the time-course patterns of in silico signalling dynamics, using deep learning method.
In this study, we also developed a new computational tool called Text2model, which transforms the descriptions of biochemical reactions into mechanistic models. Building on Text2Model, we are currently developing natural language processing (NLP) methods to automatically construct mathematical models from the literature and public databases, and to predict gene-drug interactions.
Further information here: bsc.es/research-and-development/research-seminars/sorswomeninbsc-multi-scale-cancer-signaling-network-modeling-using-natural-language-processing



![SORS: ENSO-driven variability reconfigures the altitudinal frontier of dengue risk in the Andes
Speaker:
Adrià San José, Recognized Researcher at GHR, BSC
Abstract:
Despite the high burden of dengue in Latin America, high elevations have historically protected megacities such as Mexico City, Quito, and Bogotá. Climate change is expected to shift these elevational suitability frontiers, yet most long-term projections rely solely on mean-state trends and overlook the role of climate variability, potentially underestimating risk. Using spatiotemporal decomposition techniques, we identified a mechanistic cascade linking (1) the El Niño–Southern Oscillation (ENSO) to local Colombian climate, accounting for ~85% and ~40% of interannual temperature and rainfall variability, and (2) local climate to dengue dynamics, explaining [63–76]% of incidence and [42–55]% of its altitudinal range. This cascade was further validated by model selection across formulations that incorporated both local and global climate variables. Non-linear effects indicate that dengue incidence and transmission altitude expand exponentially during warm ENSO phases, producing an upward “stretch” that exposes immunologically naïve populations in highland areas previously considered unsuitable. If ENSO extremes intensify as projected, such fluctuations may trigger large outbreaks in high-elevation urban centers, fundamentally altering the global landscape of dengue. Our findings demonstrate that climate variability, acting through local temperature and rainfall, can reconfigure the geography of risk on timescales far shorter than decadal trends. This highlights critical limitations in current projections and detection-and-attribution frameworks, underscoring the need to incorporate anthropogenically modified modes of climate variability to accurately quantify the human fingerprint on global epidemic risk. SORS: ENSO-driven variability reconfigures the altitudinal frontier of dengue risk in the Andes](https://i.ytimg.com/vi/G-l95r5gecs/mqdefault.jpg)






